Pelargonidin induces apoptosis and cell cycle arrest: Via a mitochondria mediated intrinsic apoptotic pathway in HT29 cells

RSC Advances

Volumn 6, Issue 51, 2016, Pages 45064-45076

  Karthi, N ^a   Kalaiyarasu, T ^a   Kandakumar, S ^a   Mariyappan, P ^a   Manju, V ^a  

^a PERIYAR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELLS; CYTOLOGY; DNA; MITOCHONDRIA;

ANTICANCER ACTIVITIES; CHROMATIN CONDENSATION; COLORECTAL ADENOCARCINOMA; DOSE-DEPENDENT MANNER; FLOW CYTOMETRY ANALYSIS; G2/M CELL CYCLE ARREST; MICROMOLAR CONCENTRATION; MORPHOLOGICAL CHANGES;

CELL SIGNALING;

EID: 84970946772     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c5ra20984f     Document Type: Article

References (72)

1. R. L. Siegel A. Jemal E. M. Ward Cancer Epidemiol., Biomarkers Prev. 2009 18 1695 1698
2. M. Malumbres M. Barbacid Trends Biochem. Sci. 2005 30 630 641
3. Q. Yu E. Sicinska Y. Geng M. Ahnström A. Zagozdzon Y. Kong et al. Cancer Cell 2006 9 23 32
4. M. Puyol A. Martin P. Dubus F. Mulero P. Pizcueta G. Khan et al. Cancer Cell 2010 18 63 73
5. M. G. Hu A. Deshpande M. Enos D. Mao E. A. Hinds G. F. Hu et al. Cancer Res. 2009 69 810 818
6. C. Felgines O. Texier C. Besson B. Lyan J. L. Lamaison A. Scalbert Br. J. Nutr. 2007 98 1126 1131
7. J. Beekwilder H. Jonker P. Meesters R. D. Hall I. M. van der Meer C. H. Ric de Vos J. Agric. Food Chem. 2005 53 3313 3320
8. A. Perez-Vicente P. Serrano P. Abellan C. Garcia-Viguera J. Sci. Food Agric. 2004 84 639 644
9. W. Mullen M. E. Lean A. Crozier J. Chromatogr. A 2002 966 63 70
10. M. C. Lazze M. Savio R. Pizzala O. Cazzalini P. Perucca A. I. Scovassi et al. Carcinogenesis 2004 25 1427 1433
11. O. Coqueret Trends Cell Biol. 2003 13 65 70
12. K. Fukuchi K. Nakamura S. Ichimura K. Tatsumi K. Gomi Biochim. Biophys. Acta 2003 1642 163 171
13. L. Farhana M. Dawson A. K. Rishi Y. Zhang E. Van Buren C. Trivedi et al. Cancer Res. 2002 62 3842 3849
14. F. Wolter B. Akoglu A. Clausnitzer J. Stein J. Nutr. 2001 131 2197 2203
15. A. K. Joe H. Liu M. Suzui M. E. Vural D. Xiao I. B. Weinstein Clin. Cancer Res. 2002 8 893 903
16. S. van den Heuvel E. Harlow Science 1993 262 2050 2054
17. L. H. Hartwell M. B. Kastan Science 1994 266 1821 1828
18. C. J. Sherr Science 1996 274 1672 1677
19. M. Dictor M. Ehinger F. Mertens J. Akervall J. Wennerberg Am. J. Clin. Pathol. 1999 112 S40 S52
20. P. W. Hinds Cancer Cell 2010 3 305 367
21. J. Gong F. Traganos Z. Darzynkiewicz Cell Proliferation 1995 28 337 346
22. R. J. Muschel H. B. Zhang G. Iliakis W. G. McKenna Cancer Res. 1991 51 5113 5137
23. N. F. Metting J. B. Little Radiat. Res. 1995 143 286 292
24. G. D. Kao W. G. McKenna A. Maity K. Blank R. J. Muschel Cancer Res. 1997 57 753 758
25. E. I. Azzam S. M. de Toledo T. Gooding J. B. Little Radiat. Res. 1998 150 497 504
26. J. C. Lin Y. S. Ho J. J. Lee C. L. Liu T. L. Yang C. H. Wu Food Chem. Toxicol. 2007 45 935 944
27. S. R. Kumar S. Priyatharshni V. N. Babu D. Mangalaraj C. Viswanathan S. Kannan N. Ponpandian J. Colloid Interface Sci. 2014 436 234 242
28. R. Vivek T. Ramar K. Muthuchelian P. Gunasekaran K. Kaveri S. Kannan Process Biochem. 2012 47 2405 2410
29. X. Zi A. W. Grasso H. J. Kung R. Agarwal Cancer Res. 1998 58 1920 1929
30. A. Tyagi C. Agarwal G. Harrison L. M. Glode R. Agarwal Carcinogenesis 2004 25 1711 1720
31. M. S. Donaldson Nutr. J. 2004 3 1 21
32. J. J. Wang Q. H. Shi W. Zhang B. J. Sanderson Food Chem. Toxicol. 2012 50 3004 3013
33. S. Edrini A. Rahmat P. Ismail T. Y. Hin J. Med. Sci. 2002 2 194 197
34. S. Sivalokanathan M. R. Vijayababu M. P. Balasubramanian World J. Gastroenterol. 2006 12 1018 1024
35. R. Jayadev M. R. P. Jagan V. S. Malisetty V. R. Chinthapally Cancer Epidemiol., Biomarkers Prev. 2004 13 1392 1398
36. F. L. Kiechle X. Zhang Clin. Chim. Acta 2002 326 27 45
37. T. Mishra M. Khullar A. Bhatia J. Evidence-Based Complementary Altern. Med. 2011 2011 765029
38. X. Wang Genes Dev. 2001 15 2922 2933
39. J. M. Adams S. Cory Science 1998 281 1322 1326
40. J. J. Reiners Jr J. A. Caruso P. Mathieu B. Chelladurai X. M. Yin D. Kessel Cell Death Differ. 2002 9 934 944
41. S. Fulda K. M. Debatin Oncogene 2006 25 34 4798 4811
42. M. A. Navo J. A. Smith A. Gaikwad T. Burke J. Brown L. M. Ramondetta Cancer Chemother. Pharmacol. 2008 62 483 489
43. N. Takai H. Narahara Curr. Med. Chem. 2007 14 2548 2553
44. G. I. Shapiro Cyclin-dependent kinase pathways as targets for cancer treatment J. Clin. Oncol. 2006 24 1770 1783
45. T. M. Pawlik K. Keyomarsi Role of cell cycle in mediating sensitivity to radiotherapy Int. J. Radiat. Oncol., Biol., Phys. 2004 59 4 928 942
46. J. P. Pelletier J. C. Fernandes D. V. Jovanovic P. Reboul J. Martel-Pelletier Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase J. Rheumatol. 2001 28 11 2509 2519
47. S. Lapenna A. Giordano Cell cycle kinases as therapeutic targets for cancer Nat. Rev. Drug Discovery 2009 8 547 566
48. C. Bruyère L. Meijer Targeting cyclin-dependent kinases in anti-neoplastic therapy Curr. Opin. Cell Biol. 2013 25 772 779
49. A. Goga D. Yang A. D. Tward D. O. Morgan J. M. Bishop Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC Nat. Med. 2007 13 820 827
50. J. Yuan A. Krämer Y. Matthess R. Yan B. Spänkuch R. Gätje R. Knecht M. Kaufmann K. Strebhardt Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo Oncogene 2006 25 1753 1762
51. M. C. Morris E. Gros G. Aldrian-Herrada M. Choob J. Archdeacon F. Heitz G. Divita A non-covalent peptide-based carrier for in vivo delivery of DNA mimics Nucleic Acids Res. 2007 35 e49
52. I. Androic A. Krämer R. Yan F. Rödel R. Gätje M. Kaufmann K. Strebhardt J. Yuan Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol BMC Cancer 2008 8 391
53. L. Crombez M. C. Morris S. Dufort G. Aldrian-Herrada Q. Nguyen G. Mc Master J.-L. Coll F. Heitz G. Divita Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth Nucleic Acids Res. 2009 37 4559 4569
54. M. A. Dickson G. K. Schwartz Development of cell-cycle inhibitors for cancer therapy Curr. Oncol. 2009 16 36 43
55. M. Orzáez A. Gortat L. Mondragón O. Bachs E. Pérez-Payá ATP-noncompetitive inhibitors of CDK-cyclin complexes ChemMedChem 2009 4 19 24
56. J. Cicenas M. Valius The CDK inhibitors in cancer research and therapy J. Cancer Res. Clin. Oncol. 2011 137 1409 1418
57. J. P. Pelletier F. Mineau C. Boileau J. Martel-Pelletier Diacerein reduces the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritic cartilage at the same time that it inhibits caspase-3 and inducible nitric oxide synthase Clin. Exp. Rheumatol. 2003 21 2 171 177
58. D. S. Sheth A. W. Yasko M. E. Johnson A. G. Ayala J. A. Murray M. M. Romsdahl Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery Cancer 1996 78 4 745 750
59. E. Shtivelman J. Sussman D. Stokoe A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle Curr. Biol. 2002 12 11 919 924
60. S. Pavey T. Russell B. Gabrielli Oncogene 2001 20 6103 6110
61. K. T. Christov A. L. Shikaitis E. S. Kim V. E. Steele R. A. Lubet Eur. J. Cancer 2003 39 230 239
62. T. Hunter Cell 1995 80 225 236
63. K. F. Ferri G. Kroemer Nat. Cell Biol. 2001 3 E255 E263
64. S. J. Riedl Y. Shi Nat. Rev. Mol. Cell Biol. 2004 5 897 907
65. D. R. Green J. C. Reed Science 1998 281 1309 1312
66. N. N. Danial S. J. Korsmeyer Cell 2004 116 205 219
67. G. M. Cohen Biochem. J. 1997 326 1 16
68. K. M. Boatright G. S. Salvesen Curr. Opin. Cell Biol. 2003 15 725 731
69. J. Raju J. M. Patlolla M. V. Swamy C. V. Rao Cancer Epidemiol., Biomarkers Prev. 2004 13 1392 1398
70. Y. Peng C. Li L. Chen S. Sebti J. Chen Rescue of mutant p53 transcription function by ellipticine Oncogene 2003 22 4478 4487
71. N. N. Danial S. J. Korsmeyer Cell death: critical control points Cell 2004 116 205 219
72. A. M. Chinnaiyan K. O'Rourke M. Tewari V. M. Dixit FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis Cell 1995 81 505 512